Genetic and environmental interaction analyses and risk prediction modeling
Genetic and environmental interaction analyses and risk prediction modeling
批准号:
7933451
负责人:
THOMAS A SELLERS
金额:
$59.27万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2014-03-31
关键词:
AccountingAgeAge at MenarcheAllelesApoptosisBody mass indexBreastBreast FeedingClear CellCodeCohort StudiesCollaborationsComplexContraceptive UsageDNA DamageDNA RepairDataData SetDictionaryDiseaseEarly DiagnosisEnvironmental Risk FactorEpidemiologic FactorsEpidemiologyEtiologyEvaluationFamily history ofFutureGene DosageGenesGeneticGenetic PolymorphismGenetic screening methodGenotypeGoalsHistologicHormone replacement therapyHysterectomyIndividualInfertilityInflammationInstructionInternationalInvestigationJointsLifeLife StyleMalignant NeoplasmsMalignant neoplasm of ovaryMenopauseMeta-AnalysisMethodsModelingMucinousMutationOral ContraceptivesOther GeneticsOvariectomyOxidative StressPathway interactionsPatientsPhasePlayPredispositionPregnancyPreventionProceduresRiskRisk FactorsRoleSamplingScreening for Ovarian CancerScreening procedureSerousSpecific qualifier valueStagingTest ResultTimeTubal LigationVariantWomanbasecancer genomecancer riskcase controlcohortdisorder riskendometriosisepidemiologic datagene environment interactiongene interactiongenetic associationgenetic risk factorgenome wide association studyhormone metabolismlifestyle factorsparitypreventprophylacticprospectivereproductiveresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions): N2: PrOJect 3
Ovarian cancer is a complex disease and it is likely that multiple genes and environmental factors contribute, alone and in combination, to its etiology. While the independent effects of common genetic polymorphisms and of the accepted reproductive/lifestyle risk factors are an important part of the etiolgic puzzle, the puzzle will not be complete until the role of multi-locus effects (gene-gene interactions) and interactions between reproductive/lifestyle factors and genotype are systematically explored. The goal of this project is to implement a systematic evaluation of GxG and GxE effects that applies the most advanced analytic procedures available to the most comprehensive data set on ovarian cancer susceptibility built to date. In particular, we plan to join the individual-level genetic data at each phase of this study, assembled and maintained by Project 1, with the core epidemiolgic data maintained by the Ovarian Cancer Association Consortium (OCAC) to create an analysis data set with more than 10,000 cases and 10,000 controls informative for genetic and environmental interaction effects. Compilation of the epidemiologic data is underway. The specific aims are as follows: 1) To evaluate gene-gene interactions using both agnostic and pathway-based approaches for each of the four largest histological subtypes; 2) to evaluate gene-environment interactions, for 14 epidemiologic factors, using both agnostic and pathwaybased approaches for each of the four largest histological subtypes; 3) to create a comprehensive model for absolute risk of developing ovarian cancer that incorporates family history (BRCA1/2 status), other accepted genetic and environmental factors, and those discovered (Projects 1 and 3) and functionally characterized
(Project 2) by the current study. Aims 1 and 2 share a common two-level analysis plan: a screen comprised of existing complementary methods followed by model-based evaluation of the notable interaction effects that emerge from the screen. The screen's purpose is to evaluate and coarsely prioritize as many and as diverse a set of multi-locus or multivariable GxE effects for more formal and computationally demanding multinomial response, multivariate adjusted analysis. The Aim 3 risk model will stratify patients according to whether their risk of ovarian cancer is driven by familial susceptibility (BRCA1/2) or common epidemiological and genetic risk factors. Model building for Aim 3 will focus on specifying the latter component and incorporating G, GxG and GxE effects identified in this study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative Molecular Epidemiology Workshop
-
批准号:8475082
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2013
-
负责人:THOMAS A SELLERS
-
依托单位:
Integrative Molecular Epidemiology Workshop
-
批准号:8710110
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2013
-
负责人:THOMAS A SELLERS
-
依托单位:
PROGRAM LEADERS
-
批准号:8709216
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:THOMAS A SELLERS
-
依托单位:
Integrative Molecular Epidemiology Workshop
-
批准号:8916646
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2013
-
负责人:THOMAS A SELLERS
-
依托单位:
ADMINISTRATION
-
批准号:8530504
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2012
-
负责人:THOMAS A SELLERS
-
依托单位:
ADMINISTRATION
-
批准号:8532103
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2012
-
负责人:THOMAS A SELLERS
-
依托单位:
Automated DNA Extraction System
-
批准号:8052611
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2011
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:8504772
-
项目类别:
-
资助金额:$208.43万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:8871955
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:8104223
-
项目类别:
-
资助金额:$247.89万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Functional assessment of genes and common genetic risk variants in ovarian cancer
-
批准号:7933448
-
项目类别:
-
资助金额:$58.33万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:7933445
-
项目类别:
-
资助金额:$61.88万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)
-
批准号:7933446
-
项目类别:
-
资助金额:$98.69万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:8292926
-
项目类别:
-
资助金额:$241.5万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
-
批准号:7867017
-
项目类别:
-
资助金额:$278.17万
-
财政年份:2010
-
负责人:THOMAS A SELLERS
-
依托单位:
Haplotype-Based Genome Screen for Ovarian Cancer Loci
-
批准号:7931764
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2009
-
负责人:THOMAS A SELLERS
-
依托单位:
Haplotype-Based Genome Screen for Ovarian Cancer Loci
-
批准号:7759535
-
项目类别:
-
资助金额:$110.52万
-
财政年份:2007
-
负责人:THOMAS A SELLERS
-
依托单位:
Haplotype-Based Genome Screen for Ovarian Cancer Loci
-
批准号:8025998
-
项目类别:
-
资助金额:$107.86万
-
财政年份:2007
-
负责人:THOMAS A SELLERS
-
依托单位:
Haplotype-Based Genome Screen for Ovarian Cancer Loci
-
批准号:7559676
-
项目类别:
-
资助金额:$181.53万
-
财政年份:2007
-
负责人:THOMAS A SELLERS
-
依托单位:
Haplotype-Based Genome Screen for Ovarian Cancer Loci
-
批准号:7195512
-
项目类别:
-
资助金额:$169.07万
-
财政年份:2007
-
负责人:THOMAS A SELLERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: